Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for ...

New information to be presented on the study design and methodology of Purespring’s Phase I/II trial of PS-002, an AAV-based ...

Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, today announced it will be p ...

Genesis Research Group is proud to be attending ISPOR Europe 2025 in Glasgow from 10-12th November with a strong scientific ...

ANN ARBOR, Mich., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that an oral presentation and a poster presentation have been accepted for presentation at the AHA ...

Zhang Hongwei, vice-chairman of the regional association for science and technology, outlined the transformation at a news ...

Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions ...

The center is seeking poster submissions for its annual symposium that relate specifically to this year's theme of using artificial intelligence to redefine the standard of care in medicine ...

Barresi, who is professor of biological sciences and chair of the Smith College neuroscience program, is creating artworks ...

September 2025, and the main phase was carried out from 02nd – 31 October, 2025. Apart from overall cleanliness (Swachhata) of ...

Summary of the Annual Scientific Meeting (ASM) of the Irish Pain Society (IPS) on October 18, 2025, University of Galway by ...